Effects of probiotics on the gastrointestinal tract

被引:36
作者
Snelling, AM [1 ]
机构
[1] Univ Bradford, Dept Biomed Sci, Bradford BD7 1DP, W Yorkshire, England
关键词
alternative therapeutics; gastrointestinal disease; gastrointestinal tract infection; lactobacilli; probiotics;
D O I
10.1097/01.qco.0000182103.32504.e3
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of review This review. summarizes recent developments in our understanding of what gastrointestinal disorders probiotics can be of benefit for, focussing on conditions associated with infection or disruption of the normal gut flora. New insights into the effects administered strains can have in the, gut their safety,and potential for future development, Will also be discussed. Recent findings Recent clinical studies have shown that probiotics can p protect young children from diarrhoeal illness, including antibiotic-associated diarrhoea. They may also protect neonates from necrotizing enterocolitis. In. adults, they can help prevent or reduce the severity of diarrhoeal illness, and ameliorate side-effects for those undergoing antibiotic therapy for infection. Researchers are looking at combining probiotics, with prebiotics to enhance anti-inflammatory effects and restore colonization resistance of the commensal flora. New technologies are elucidating complex effects on gene expression in the gut, the probiotic, and bacterial pathogens. Recombinant strains capable of binding bacterial toxins are being developed, as novel therapeutics against gastrointestinal infection. Summary Considering the clinical trial evidence of therapeutic benefit, probiotics are an treatment modality for prevention and amelioration of diarrhoeal illness. Better understanding of strain-specific effects, dosing regimens and any contraindications should help resolve this.
引用
收藏
页码:420 / 426
页数:7
相关论文
共 77 条
[1]  
Allen S.J., 2004, COCHRANE DB SYST REV, pCD003048, DOI [10.1002/14651858.CD003048.pub2, DOI 10.1002/14651858.CD003048.PUB2]
[2]   The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens [J].
Altenhoefer, A ;
Oswald, S ;
Sonnenborn, U ;
Enders, C ;
Schulze, J ;
Hacker, J ;
Oelschlaeger, TA .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2004, 40 (03) :223-229
[3]   Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM [J].
Altermann, E ;
Russell, WM ;
Azcarate-Peril, MA ;
Barrangou, R ;
Buck, BL ;
McAuliffe, O ;
Souther, N ;
Dobson, A ;
Duong, T ;
Callanan, M ;
Lick, S ;
Hamrick, A ;
Cano, R ;
Klaenhammer, TR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (11) :3906-3912
[4]   Probiotic bifidobacteria protect mice from lethal infection with shiga toxin-producing Escherichia coli O157:H7 [J].
Asahara, T ;
Shimizu, K ;
Nomoto, K ;
Hamabata, T ;
Ozawa, A ;
Takeda, Y .
INFECTION AND IMMUNITY, 2004, 72 (04) :2240-2247
[5]   Synbiotics to strengthen gut barrier function and reduce morbidity in critically ill patients [J].
Bengmark, S .
CLINICAL NUTRITION, 2004, 23 (04) :441-445
[6]   Identification of Lactobacillus plantarum genes that are induced in the gastrointestinal tract of mice [J].
Bron, PA ;
Grangette, C ;
Mercenier, A ;
de Vos, WM ;
Kleerebezem, M .
JOURNAL OF BACTERIOLOGY, 2004, 186 (17) :5721-5729
[7]  
Burton J P, 2005, Oral Dis, V11 Suppl 1, P29, DOI 10.1111/j.1601-0825.2005.01084.x
[8]   Quantitative analysis of diverse Lactobacillus species present in advanced dental caries [J].
Byun, R ;
Nadkarni, MA ;
Chhour, KL ;
Martin, FE ;
Jacques, NA ;
Hunter, N .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (07) :3128-3136
[9]   Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis [J].
Cherifi, S ;
Robberecht, J ;
Miendje, Y .
ACTA CLINICA BELGICA, 2004, 59 (04) :223-224
[10]   Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria [J].
Cross, ML ;
Ganner, A ;
Teilab, D ;
Fray, LM .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2004, 42 (02) :173-180